Ticagrelor is an antiplatelet medication that prevents blood clots by inhibiting the P2Y12 receptor on platelets. It is commonly prescribed after heart attacks or stent placement to reduce the risk of recurrent cardiovascular events. Unlike clopidogrel, it acts faster and does not require metabolic activation.